Related by context. Frequent words. (Click for all words.) 61 INTERCEPT Blood System 58 CMV disease 58 coagulation factors 57 pathogen inactivation 57 acute GVHD 56 INTERPRETING REPORTING OR DELIVERING 55 By KATHRYN MARTINEZ 55 CAUSED IN WHOLE OR 55 IS PROVIDED AS IS 55 BY MARK CURNUTTE 55 CMV infection 54 ITS CONTENTS 54 OF SOURCES FROM WHICH 54 PART OF ANY OTHER 54 THE COMPANY WHO TAKES 54 MUST CLICK ON 54 ANY RESPONSIBILITY FOR ANY 54 MADE BASED UPON 54 WHICH ARE NOT PURELY 54 THE EXPRESSED WRITTEN CONSENT 53 Evo IX +# mins 53 ASIC accelerated 53 THE TERMS AND CONDITIONS 53 Trouvez d' autres articles 53 HYPOTHETICAL OR SIMULATED PERFORMANCE 53 FROM USE OF 53 articles d' IRIN 53 sont publiés sur ReliefWeb 53 By HOWARD WEISS 53 Marcus Gronholm BP 53 COPIED OR REPRODUCED IN 53 d' IRIN sur http:/www.irinnews.org 53 TO POTENTIALLY REBOUND AFTER 53 ACCURACY COMPLETENESS CURRENTNESS TIMELINESS 53 Valcyte 53 Pegasys ® 52 VERINT logo ACTIONABLE INTELLIGENCE 52 IN TURBO WARRANTS REPRESENTS 52 unten stehenden Link 52 romiplostim 52 therapeutic regimens 52 Une sélection d' 52 SEE CONTINUED DOWNWARD MOMENTUM 52 PROFESSIONAL FINANCIAL ADVISER BEFORE 52 By BOB FOWLER 52 antibiotic prophylaxis 52 RESPONSIBLE FOR ANY DELAY 51 By HAVIV RETTIG 51 ANY LOT 51 HEREBY DISCLAIMS ANY SUCH 51 iron overload 51 EVANGELIST Staff writer 51 IT WILL CONTAIN 51 FEEDS & 51 CIRCULATED OR INCLUDED AS 51 viruses worms Trojans 51 PRICE GREAT DISCOUNT FREE 51 YOUR STOCKBROKER OR OTHER 51 THAT AN INVESTMENT 51 hemolysis 51 morbidity mortality 51 NOR SHALL THERE 50 immunosuppressive agents 50 irresponsible nuisances 50 AND SHOULD ALSO 50 blood borne pathogens 50 endophthalmitis 50 % POTENTIAL UPSIDE 50 D dimer 50 allogeneic 50 SHALL NOT BE LIABLE 50 STORED DOWNLOADED ABSTRACTED DISSEMINATED 50 RESULTS PERFORMANCE OR ACHIEVEMENTS 50 WATCH FOR CONTINUED GAINS 50 TRADING HIGHER ON HEAVY 50 FVIII 50 TO YOU OR ANYONE 50 azacitidine 50 immunosuppression 50 aux abonnés 50 hematopoietic cell 50 THE MORTGAGOR THE MORTGAGOR 49 Transfusions 49 uncontrolled bleeding 49 GREATER DEGREE OF RISK 49 Nortel remedial 49 Cet article ne reflète 49 VOLUME ARE SHARES OF 49 THAN AN INVESTMENT 49 allogeneic stem cell 48 febrile neutropenia 48 transfused blood 48 navigator.appName & navigator.appName.indexOf Netnavigator.appVersion.indexOf 2 48 Secondary endpoints included 48 REPORT ITS QUARTERLY 48 warfarin therapy 48 anticoagulant therapy 48 ELSE FOR ANY DAMAGES 48 GVHD 48 gamma globulin 47 hemolytic anemia